You are here

  • Home
  • Archive
  • Volume 5, Issue 1
  • Sudden hearing loss in a melanoma patient on pembrolizumab: an etiology not to be omitted in the differential diagnosis

Article metrics

Article menu

Download PDFPDF

Commentary
Sudden hearing loss in a melanoma patient on pembrolizumab: an etiology not to be omitted in the differential diagnosis

 

Online download statistics by month:

Online download statistics by month: December 2019 to July 2025

AbstractFullPdf
Dec 2019110
Jan 2020110
Feb 2020881
Mar 2020441
Apr 2020770
May 202018182
Jun 202013130
Jul 202010102
Aug 202012122
Sep 202020200
Oct 202027271
Nov 202014132
Dec 2020993
Jan 202111110
Feb 202115151
Mar 202118180
Apr 202111111
May 202115152
Jun 202111110
Jul 202114143
Aug 2021772
Sep 202112123
Oct 202119193
Nov 202114144
Dec 202114141
Jan 202221221
Feb 202214164
Mar 202229295
Apr 202231321
May 202236363
Jun 202246461
Jul 202229302
Aug 202262624
Sep 202249492
Oct 202257576
Nov 2022414312
Dec 202228283
Jan 202332323
Feb 202355550
Mar 202329304
Apr 202329291
May 202336366
Jun 202344444
Jul 202346466
Aug 202357576
Sep 202348481
Oct 202351511
Nov 202373736
Dec 202355552
Jan 202410112
Feb 202464644
Mar 20241041083
Apr 20241021023
May 202498982
Jun 202465652
Jul 202416016412
Aug 20241211196
Sep 20241131148
Oct 20241391398
Nov 20241141154
Dec 202485864
Jan 20251101107
Feb 202597970
Mar 20251001009
Apr 20251161168
May 202595954
Jun 202574744
Jul 2025110
Total30713088208